COVENANT GOVERNMENT AFFAIRS, LLC

Lobbying for QUERCIS PHARMA AG · Manufacturing

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $20,000.00 income · posted Jul 9, 2026

Lobbying activity 1

Manufacturing

Kinisoquin clinical trial recruitment for the VTE/Oncology drug trial with VA hospital system

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem